Trial Profile
The change of IMT of carotide artery in RA with treatment of tocilizumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 May 2017 New trial record